Nebulizer

2020 Nebulizers Market Analysis & Forecast Model (COVID-19 Impact) - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 11, 2020
Medical devices, Health, Health, Medical equipment, Aerosols, Dosage forms, Respiratory therapy, Medicine, Nebulizer, Occupational safety and health, Impact of the COVID-19 pandemic, Coronavirus disease

The "Nebulizers (Anesthesia and Respiratory Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Nebulizers (Anesthesia and Respiratory Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.
  • The market model is built to visualize quantitative market trends within Anesthesia and Respiratory Devices therapeutic area.
  • This model discusses in detail the impact of COVID-19 on Nebulizers market for the year 2020 and beyond.
  • The model will enable you to:
    Understand the impact of COVID-19 on Nebulizers market.

Nebulizers Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth

Retrieved on: 
Wednesday, July 22, 2020
Health, Aerosols, Medical equipment, Nebulizer, Respiratory therapy, Marketing, Medicine

NEW YORK, July 22, 2020 /PRNewswire/ -- Nebulizers Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth provides the strategists, marketers and senior management with the critical information they need to assess the global nebulizers market.

Key Points: 
  • NEW YORK, July 22, 2020 /PRNewswire/ -- Nebulizers Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth provides the strategists, marketers and senior management with the critical information they need to assess the global nebulizers market.
  • The global nebulizers market opportunities and strategies to 2030 report answers all these questions and many more.
  • Market Characteristics The market characteristics section of the report defines and explains the nebulizers market.
  • Market Opportunities And Strategies This section includes market opportunities and strategies based on findings of the research.

Global Self-inflating Bag Market 2020-2024 | Evolving Opportunities with Aero Healthcare AU Pty Ltd. and Ambu AS | Technavio

Retrieved on: 
Tuesday, July 14, 2020
Medical devices, Health, Health, Medical equipment, Respiratory therapy, Dosage forms, Aerosols, Medicine, Nebulizer, AERO

With the increasing number of COVID-19 cases across the world, the growth of the global self-inflating bag market will gain momentum during the forecast period.

Key Points: 
  • With the increasing number of COVID-19 cases across the world, the growth of the global self-inflating bag market will gain momentum during the forecast period.
  • In addition, the rising adoption of 3D printing is anticipated to boost the growth of the self-inflating bag market.
  • Major Five Self-Inflating Bag Companies:
    Aero Healthcare AU Pty Ltd.
    Aero Healthcare AU Pty Ltd. operates its business through the Emergency medical products segment.
  • Global Nebulizers Market Global nebulizers market by geography (Asia, Europe, North America, and ROW) and product (pneumatic nebulizers, mesh nebulizers, and ultrasonic nebulizers).

Hillrom Launches Two New Respiratory Health Innovations: Volara™ System for Oscillation and Lung Expansion Therapy, and Synclara™ Cough System

Retrieved on: 
Monday, July 13, 2020
Medicine, Health, Medical equipment, Respiratory therapy, Intensive care medicine, Cough, Nebulizer, Positive airway pressure

CHICAGO, July 13, 2020 /PRNewswire/ --Global medical technology leaderHillrom (NYSE: HRC) today announced the launch of two new respiratory therapy devices: the Volara System, which provides hospital-grade oscillation and lung expansion (OLE) therapy, and the Synclara Cough System.

Key Points: 
  • CHICAGO, July 13, 2020 /PRNewswire/ --Global medical technology leaderHillrom (NYSE: HRC) today announced the launch of two new respiratory therapy devices: the Volara System, which provides hospital-grade oscillation and lung expansion (OLE) therapy, and the Synclara Cough System.
  • The Volara System delivers trusted OLE therapy, combining Continuous Positive Expiratory Pressure (CPEP), Continuous High-Frequency Oscillation (CHFO) and a nebulizer in one portable, lightweight device.
  • The Synclara Cough System is a non-invasive therapy that simulates a cough to remove secretions in patients with compromised peak cough flow.
  • The Volara System and Synclara Cough System are available in the United States.

Global Nebulizers Market (2020 to 2025) - Outlook and Forecast

Retrieved on: 
Wednesday, July 8, 2020
Health, Companies, Respiratory therapy, Dosage forms, Medical equipment, Aerosols, Nebulizer, Omron, Philips, Market

DUBLIN, July 8, 2020 /PRNewswire/ -- The "Nebulizers Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 8, 2020 /PRNewswire/ -- The "Nebulizers Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • The global nebulizer market is one of the steady growing segments in the global medical devices market.
  • The global nebulizer market share is fragmented with the presence of several global, regional, and local vendors offering a wide range of devices.
  • OMRON, Koninklijke Philips, Drive DeVilbiss International, PARI, Feellife Health, Besco Medical, and Rossmax International, and Ca-Mi are the key market players dominating the market.

Insights on the Nebulizers Global Market to 2025 - Featuring Big Eagle, Bremed & Well Swiss Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, July 6, 2020
Medical devices, Health, Respiratory therapy, Health, Aerosols, Dosage forms, Medical equipment, Nebulizer, Medicine

The nebulizer market by revenue is expected to grow at a CAGR of over 7% during the period 2019-2025.

Key Points: 
  • The nebulizer market by revenue is expected to grow at a CAGR of over 7% during the period 2019-2025.
  • The global nebulizer market is one of the steady growing segments in the global medical devices market.
  • According to the WHO, COPD is expected to emerge as the third leading cause of death across the world by 2025.
  • The global nebulizer market share is fragmented with the presence of several global, regional, and local vendors offering a wide range of devices.

Smart Inhalers Market Size to Reach USD 1406 Million by 2026 - Valuates Reports

Retrieved on: 
Wednesday, July 1, 2020
Dosage forms, Respiratory therapy, Health, Medicine, Aerosols, Medical equipment, Nebulizer, Inhaler

The global Nebulizers market size is valued at 797 million USD in 2020 is expected to reach 1125.7 million USD by the end of 2026, growing at a CAGR of 5.0% during 2021-2026.

Key Points: 
  • The global Nebulizers market size is valued at 797 million USD in 2020 is expected to reach 1125.7 million USD by the end of 2026, growing at a CAGR of 5.0% during 2021-2026.
  • The global Dry Powder Inhalers market size is valued at 3201.1 Million USD in 2020 is expected to reach 3632 Million USD by the end of 2026, growing at a CAGR of 1.8% during 2021-2026.
  • The global Digital Dose Inhaler market size is projected to reach USD 1384.4 Million by 2026, from USD 1244 Million in 2020, at a CAGR of 10.4%% during 2021-2026.
  • The global Respiratory Inhalers market size is projected to reach USD 29220 Million by 2026, from USD 28800 Million in 2020, at a CAGR of 1.3%% during 2021-2026.

Smart Inhalers Market Size to Reach USD 1406 Million by 2026 - Valuates Reports

Retrieved on: 
Wednesday, July 1, 2020
Dosage forms, Respiratory therapy, Health, Medicine, Aerosols, Medical equipment, Nebulizer, Inhaler

The global Nebulizers market size is valued at 797 million USD in 2020 is expected to reach 1125.7 million USD by the end of 2026, growing at a CAGR of 5.0% during 2021-2026.

Key Points: 
  • The global Nebulizers market size is valued at 797 million USD in 2020 is expected to reach 1125.7 million USD by the end of 2026, growing at a CAGR of 5.0% during 2021-2026.
  • The global Dry Powder Inhalers market size is valued at 3201.1 Million USD in 2020 is expected to reach 3632 Million USD by the end of 2026, growing at a CAGR of 1.8% during 2021-2026.
  • The global Digital Dose Inhaler market size is projected to reach USD 1384.4 Million by 2026, from USD 1244 Million in 2020, at a CAGR of 10.4%% during 2021-2026.
  • The global Respiratory Inhalers market size is projected to reach USD 29220 Million by 2026, from USD 28800 Million in 2020, at a CAGR of 1.3%% during 2021-2026.

BetterLife Pharma (OTCQB:BETRD) Believe Inhalation Device Containing Proprietary Interferon May Fight Off COVID-19

Retrieved on: 
Tuesday, June 30, 2020
Cytokines, Health, Medicine, Antivirals, Interferon, Branches of biology, Nebulizer, IFNA2, Multiple sclerosis

Interferon beta is already used as an injection to boost the immune response of people with multiple sclerosis.

Key Points: 
  • Interferon beta is already used as an injection to boost the immune response of people with multiple sclerosis.
  • But if the drug is inhaled via a handheld nebuliser, IFNa2b can be delivered directly to the lungs where it can help fight COVID-19 at the source.
  • Fish is now on the Advisory Board of BetterLife Pharma and is advising on the upcoming trials.
  • AP-003 will contain BetterLifes patent-pending and purer composition of IFNa2b, which our bodies produce when we get a viral infection.

BetterLife Pharma (OTCQB:BETRF): How a Simple Inhaler May Fight Off COVID-19

Retrieved on: 
Monday, June 29, 2020
Cytokines, Health, Medicine, Antivirals, Interferon, Branches of biology, Nebulizer, IFNA2, Multiple sclerosis

Interferon beta is already used as an injection to boost the immune response of people with multiple sclerosis.

Key Points: 
  • Interferon beta is already used as an injection to boost the immune response of people with multiple sclerosis.
  • But if the drug is inhaled via a handheld nebuliser, IFNa2b can be delivered directly to the lungs where it can help fight COVID-19 at the source.
  • Fish is now on the Advisory Board of BetterLife Pharma and is advising on the upcoming trials.
  • AP-003 will contain BetterLifes patent-pending and purer composition of IFNa2b, which our bodies produce when we get a viral infection.